Biological Computing.
Printed, Not Built.
A fabrication platform that 3D-prints self-sustaining organoid intelligence chips — combining printed multi-electrode arrays, automated organoid culture, and electrophysiological monitoring — at a fraction of current device costs. Built on the same Rister toolchanger platform developed for Nanosolar Tile BIPV. biological computing at a fraction of current costs. Built on the same Rister toolchanger platform developed for Nanosolar Tile.
accuracy: sub-mm
transmission
silicon AI inference
vs. $25k+ CL1
One Platform, Two Breakthroughs
The Rister toolchanger platform was purpose-built for precision multi-material deposition on flexible substrates. Originally developed for Nanosolar Tile perovskite BIPV fabrication, the same platform — with its heated dispensing, camera-guided alignment, and mid-run tool exchange — maps directly onto the full MEA-OI Fab fabrication workflow: from multi-electrode array printing to hydrogel seeding to automated organoid culture.
No substrate removal. No cleanroom. No $100k commercial instrument. A single integrated fabrication run from bare substrate to powered organoid chip.
What Makes This Possible
- Mid-run tool exchange with sub-mm coordinate integrity — enables sequential deposition of electrode, biological, and structural materials on one substrate
- Camera-guided organoid placement — fiducial referencing ensures each organoid contacts multiple electrode recording sites
- Heated dispensing at 60°C with PTFE fluid paths — compatible with hydrogel precursors, conductive electrode inks, and biocompatible materials
- Electrophysiological viability monitoring via MEA — spike frequency and network synchrony tracked throughout culture without optical instrumentation
- Sterile, closed-loop fluid management — automated media exchange keeps organoids viable without contamination
- In-house fabricated syringe pumps and tool heads — adding channels means printing hardware, not purchasing proprietary components
Platform Capabilities
The MEA-OI Fab workflow requires sequential deposition of electrically conductive and biologically compatible materials, plus automated biological tissue handling. The Rister platform addresses all three without substrate removal.
7-Step MEA-OI Fab Fabrication
Complete organoid intelligence chip fabrication on a single platform — from bare ITO-PET or glass substrate to electrode-interfaced organoid culture — without substrate removal at any step.
MEA Electrode Printing
Conductive traces and multi-electrode array deposited on cleaned substrate. Silver or carbon-based interconnects, then biocompatible electrode material (PEDOT:PSS or gold nanoparticles). UV curing or low-temperature anneal per layer.
Liquid Dispensing Tool UV Curing ToolCulture Chamber Fabrication
Structural sidewalls and shallow well printed in biocompatible PETG around the electrode base. Sealed edges maintain sterility and humidity. Alignment features and media exchange ports integrated.
FDM Extrusion ToolHydrogel Matrix Deposition
Biocompatible hydrogel precursor (Matrigel or collagen-based) precisely dispensed onto electrode array to form a supportive 3D matrix for organoid attachment and growth.
Heated Dispensing Tool · 37°COrganoid Seeding & Placement
Neural progenitor cells or pre-formed mini-organoids aspirated and deposited in controlled droplets onto the electrode array. Camera-guided alignment ensures contact with multiple recording sites. Pick-and-place gripper tool available for larger spheroids.
Liquid Dispensing Tool Camera Inspection ToolOrganoid Maturation (Days–Weeks)
Organoids grow and form functional neural networks in the sealed chamber. Automated media refreshes delivered via dispensing tool on a scheduled cycle. Remote monitoring via camera tool.
Automated Media ExchangeElectrophysiological Monitoring & Lid Transition
MEA records spontaneous neural activity throughout culture. Upon maturation, gripper tool removes culture lid and seats a transparent PETG enclosure providing optical access for transmitted-light imaging and optogenetic stimulation.
Thin-Film Deposition Tool · ≤100°CEncapsulation & Integration
Moisture/oxygen barrier encapsulation. On-chip low-power electronics connected via printed traces: neural signal amplifiers, stimulus delivery microcontrollers, and optional optogenetic feedback loops.
UV Curing ToolBiological Computing — Why Now
In 2022, Cortical Labs demonstrated that lab-grown neurons on a silicon chip could teach themselves to play Pong — using a fraction of the energy required by any silicon AI system. Their CL1 device, released in 2025, is the first commercially available biological computer. It costs approximately $25,000 and requires specialized lab infrastructure to operate.
The fabrication bottleneck is the limiting factor. Organoid intelligence chips are not limited by the biology — they are limited by the cost, accessibility, and scalability of chip fabrication. MEA-OI Fab addresses this directly.
Why Organoid Intelligence
- Neurons consume ~10 fJ per synaptic operation — versus ~1 nJ for a silicon transistor operation — approximately 100,000× more energy efficient
- Biological neural networks learn from dramatically smaller datasets than conventional deep learning models
- 3D organoid architecture enables densities impossible in 2D silicon — billions of synaptic connections in a cubic millimeter
- Inherently adaptive — organoids self-organize, rewire, and learn in response to stimulation without explicit programming
- Potential for personalized medicine applications — patient-derived organoids for drug screening and disease modeling
- Optogenetic compatibility — transparent PETG/PDMS enclosure enables light-based neural stimulation and readout through the lid
The Convergence Moment
Three curves are crossing simultaneously: organoid intelligence has been experimentally validated (Cortical Labs, Johns Hopkins, Lieber Group). And additive manufacturing platforms have crossed the threshold for multi-material biological fabrication. MEA-OI Fab sits at both intersections. reached commercial viability. And additive manufacturing platforms have crossed the threshold for multi-material biological fabrication. MEA-OI Fab sits at both intersections.
Primary Market Vectors
- Neuroscience research tools — Low-cost MEA + organoid fabrication kits for academic and biotech labs currently limited by cleanroom fabrication costs
- DARPA BTO programs — Resilient, off-grid bio-hybrid computing platforms for autonomous systems — exactly the self-powered, ambient-energy profile DARPA values
- Pharmaceutical drug screening — Patient-derived organoid chips for CNS drug testing at a cost point enabling high-throughput screening
- Sustainable AI infrastructure — As GPU cluster energy costs become politically untenable, bio-computing offers a credible low-energy alternative for specific inference workloads
- Optogenetics platforms — The transparent biocompatible enclosure enables light-based neural stimulation and readout — a unique capability not available in any current commercial device
Adjacent Application Areas
The MEA-OI Fab platform produces the organoid chip as its primary application — but the platform capabilities enable a broader portfolio.
Development Roadmap
MEA-OI Fab is built on the validated Rister platform, leveraging existing hardware, firmware, and process IP from the Nanosolar Tile program. Development proceeds in parallel with BIPV work, sharing infrastructure costs.
Rister Platform Validation — Complete
Multi-material toolchanger, heated dispensing, camera-guided placement, and fluid management validated with mimic inks. Control software (Printer Designer, Array Management) operational.
MEA Fabrication & Characterization
Print first PEDOT:PSS and gold nanoparticle MEA arrays on ITO-PET. Characterize electrode impedance and signal-to-noise. Establish biocompatible chamber printing workflow.
First Organoid Seeding on Printed MEA
Neural organoid or progenitor cell culture in printed chamber. Demonstrate viability and electrode recording. Lab partnership for electrophysiology characterization.
Signal Integration & Closed-Loop Culture
Connect MEA to low-power recording electronics via printed conductive traces. Validate automated culture cycle with electrophysiological monitoring. Demonstrate neural activity recording from matured organoid network.
First Closed-Loop Demo — Ambient-Powered Neural Recording
Demonstrate complete MEA-OI Fab chip: organoid neural activity recorded via printed MEA, connected to low-power recording electronics via on-chip printed traces. First paying lab customer for fabrication service.
Get Involved
Seeking accelerator programs, lab partnerships (organoid culture, electrophysiology characterization), and early-stage investors aligned with synthetic biology, advanced manufacturing, and sustainable computing. Also open to conversations with researchers interested in applying the platform to new biological computing applications.
Partnership Interests
- Academic neuroscience labs with organoid culture and MEA characterization capability — platform provides fabrication, lab provides biological expertise
- Biotech companies developing organ-on-chip or organoid-based drug screening platforms — licensing the fabrication workflow
- DARPA or IARPA program offices exploring bio-hybrid autonomous computing
- Angel investors and family offices with deep tech or longevity/bio portfolio focus